Just out of interest did any note this inthe newletter from Griffin Security. 01 May 2012 document contained their previous and current opinions as below:
2/24/2012 – Updating Coverage: share price: $2.35; rating: BUY; 12-month price target:
$14.00;
5/1/2012 – Updating Coverage: share price: $2.24; rating: BUY; 12-month price target: $14.00.
Are these guys just contrarians or are they in the ballpard once the Partner or FDA issues are resolved?
OOG